# Zyversa Therapeutics, Inc.: Form D filings

Zyversa Therapeutics, Inc., a pharmaceuticals company in Weston, FL, filed 9 Form D notices with the SEC between 2014 and 2022. The latest, on April 14, 2022, reports $419,320 sold of a $7 million offering to 4 investors.

Find out what Zyversa Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Zyversa%20Therapeutics%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Zyversa%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fzyversa-therapeutics-inc-1613083)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Zyversa%20Therapeutics%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Zyversa%20Therapeutics%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fzyversa-therapeutics-inc-1613083)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Florida](https://specstream.ai/data/form-d/state/florida): 2,702 rows, by operating companies, filed since November 1, 2024, $107.02, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/florida
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2200 N. COMMERCE PARKWAY, SUITE 208, Weston, FL, 33326
- Phone: (646) 414-6965
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Florida
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1613083

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 14, 2022 | New notice | $7,000,000 | $419,320 | $6,580,680 | 4 | Mar 30, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613083/000090571822000603/0000905718-22-000603-index.htm) |
| Nov 1, 2019 | New notice | $20,000,000 | $1,277,500 | $18,722,500 | 19 | Oct 22, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613083/000090571819000894/0000905718-19-000894-index.htm) |
| Feb 5, 2018 | New notice | $1,651,669 | $1,403,627 | $248,042 | 20 | Jan 19, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613083/000090571818000109/0000905718-18-000109-index.htm) |
| Mar 2, 2017 | New notice | $7,000,000 | $525,000 | $6,475,000 | 7 | Jan 6, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613083/000090571817000323/0000905718-17-000323-index.htm) |
| Oct 26, 2016 | Amendment | $4,000,000 | $1,505,000 | $2,495,000 | 21 | Mar 11, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613083/000090571816001715/0000905718-16-001715-index.htm) |
| Apr 21, 2016 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613083/000090571816001361/0000905718-16-001361-index.htm) |
| Jan 21, 2016 | New notice | $25,000,000 | $0 | $25,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613083/000090571816001092/0000905718-16-001092-index.htm) |
| Feb 3, 2015 | Amendment | $3,500,000 | $2,980,000 | $520,000 | 17 | Jul 15, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613083/000161308315000001/0001613083-15-000001-index.htm) |
| Jul 11, 2014 | New notice | $2,500,000 | $0 | $2,500,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1613083/000161308314000001/0001613083-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Melda Uzbil O'Connell | Executive Officer |  |
| Nick LaBella | Executive Officer |  |
| Stephen Glover | Executive Officer, Director |  |
| Robert G Finizio | Director |  |
| Peter Wolfe | Executive Officer |  |
| Minchul G Park | Director |  |
| Pablo Guzman | Executive Officer |  |
| Karen Cashmere | Executive Officer |  |

## Other pharmaceuticals companies in Florida that filed recently

- [GOA Therapeutics Corp](https://specstream.ai/data/form-d/company/goa-therapeutics-corp-2131824) $300,000 · Nov 5, 2026
- [DalCor Pharmaceuticals US, LLC](https://specstream.ai/data/form-d/company/dalcor-pharmaceuticals-us-llc-1673368) $7 million · Aug 28, 2026

[Every Form D from the week of Apr 11, 2022](https://specstream.ai/data/form-d/week/2022-04-11) · [All recent filings in Florida](https://specstream.ai/data/form-d/state/florida) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Zyversa Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).